Cafepharma Today

May 19 2025 - Regeneron wins bid to buy 23andMe out of bankruptcy
Regeneron wins bid to buy 23andMe out of bankruptcy
Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant
Japan follows UK in GSK's comeback tour for Blenrep
FDA clears Novavax’s COVID-19 vaccine with usage restrictions
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

2 Life Sciences IPOs Debut Below Target
Seeking Alpha
Sunday, February 5, 2012 - 12:15pm
tags:
Greenway Medical Technologies, Cempra
Lupin Limited: Buy
Hindu Business Line, India
Saturday, February 4, 2012 - 5:06pm
tags:
Lupin
New rules could save billions in prescription drug costs
Boston Herald, MA
Saturday, February 4, 2012 - 5:05pm
tags:
Medicaid
Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
BioMedReports
Saturday, February 4, 2012 - 5:01pm
tags:
Threshold Pharmaceuticals, Merck KGaA, TH-302, sarcoma, pancreatic cancer
7 Healthcare Stocks Undervalued By Earnings Growth And Cash Flows
Seeking Alpha
Saturday, February 4, 2012 - 4:54pm
tags:
PDL Biopharma, Wellpoint, Aetna, USANA Health Sciences, Cumberland, Depomed, Acadia
Pharmaceutical and Medical Device Companies Shift Medical Education Focus into Emerging Markets
Sacramento Bee, CA
Saturday, February 4, 2012 - 4:51pm
tags:
Is Novo Nordisk Really the Most Sustainable Company in the World?
Triple Pundit
Saturday, February 4, 2012 - 4:47pm
tags:
Novo Nordisk
Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/Ovral®-28 and Norgestrel Birth Control Pill Recall
Yahoo/BusinessWire
Saturday, February 4, 2012 - 4:40pm
tags:
Pfizer, lawsuits, recalls
Eli Lilly Freezes Salaries as Sales Slip After Best-Seller Faces Generics
Bloomberg
Saturday, February 4, 2012 - 4:38pm
tags:
Eli Lilly, Zyprexa, generics
Curing Diseases Makes For a Bad Business Model (Vertex and Hepatitis C)
Motley Fool
Saturday, February 4, 2012 - 4:37pm
tags:
Vertex Pharmaceuticals, hepatitis C, Incivek
AstraZeneca - Solid Earnings Overwhelmed By An Uncertain Future
Seeking Alpha
Saturday, February 4, 2012 - 4:34pm
tags:
AstraZeneca
Merck Looks Like A Name To Own In Drugs
Seeking Alpha
Saturday, February 4, 2012 - 4:34pm
tags:
Merck
BioLineRx: Strong Speculation Bio-Pharma, Strong Acquisition Target
Seeking Alpha
Saturday, February 4, 2012 - 3:36pm
tags:
BioLineRx
Brower Piven Files Class Action Suit Against GenVec, Inc
Yahoo/MarketWire
Saturday, February 4, 2012 - 3:34pm
tags:
GenVec, lawsuits
The 9 Biotechs With The Highest Growth Expectations
Seeking Alpha
Saturday, February 4, 2012 - 3:29pm
tags:
Theratechnologies, SeraCare Life Sciences, Gentium, Curis, BioDelivery Sciences, Amarin, Affymetrix, Affymax, Vertex Pharmaceuticals
What's Going on With These Biotech Stocks?
Motley Fool
Saturday, February 4, 2012 - 3:26pm
tags:
Cell Therapeutics, BioSante, Teva Pharmaceuticals, Aduro BioTech, Ariad Pharmaceuticals, Merck
Questcor Beats Estimates With Prelim Q4 Results
Investors.com
Saturday, February 4, 2012 - 3:24pm
tags:
Questcor Pharmaceuticals
Vical Inc.: A $3 Biotech Lottery Ticket I Am Buying Now
Seeking Alpha
Saturday, February 4, 2012 - 3:23pm
tags:
Vical, Allovectin, melanoma
What's behind call action in ViroPharma
Yahoo/Option Monster
Saturday, February 4, 2012 - 3:21pm
tags:
ViroPharma
Abbott, Hospira Win Appellate Affirmation in Spinoff Retirement Lawsuit
Bloomberg
Friday, February 3, 2012 - 12:36pm
tags:
Abbott Laboratories, Hospira

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.